Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombocytopenia in pregnancy.

Rubina Karim1, Ronald A Sacher

  • 1University of Cincinnati Medical Center, 3130 Highland Avenue, PO Box 670055, Cincinnati, OH 45267, USA.

Current Hematology Reports
|February 18, 2004
PubMed
Summary

Pregnancy-associated thrombocytopenia affects 7-10% of pregnant individuals, with severe cases below 50 x 10(9)/L being rare (<0.1%). Routine prenatal screenings now commonly detect these platelet count changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PRESIDENT'S ADDRESS: WINE, WATER, AND WELLNESS.

Transactions of the American Clinical and Climatological Association·2019
Same author

Thomas F. Zuck.

Transfusion·2015
Same author

Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study.

Transfusion·2011
Same author

Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study.

Transfusion·2010
Same author

Increased all-cause and cancer mortality in HTLV-II infection.

Journal of acquired immune deficiency syndromes (1999)·2010
Same author

Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection.

Blood·2008

Area of Science:

  • Obstetrics and Gynecology
  • Hematology

Background:

  • Thrombocytopenia, a low platelet count (<150,000/mL), is frequently identified during routine prenatal screenings.
  • Automated blood cell counters in prenatal diagnostics have increased the detection rate of thrombocytopenia in pregnancy.

Purpose of the Study:

  • To summarize the incidence and prevalence of thrombocytopenia in pregnancy.
  • To highlight the rarity of severe thrombocytopenia during gestation.

Main Methods:

  • Review of epidemiological data on platelet counts in pregnant populations over the past 20 years.
  • Analysis of data from routine prenatal screenings including automated blood cell counts.

Main Results:

  • Thrombocytopenia is observed in 7% to 10% of unselected pregnancies.
  • Severe thrombocytopenia (platelet count <50 x 10(9)/L) occurs in less than 0.1% of pregnancies.

Conclusions:

  • Pregnancy-associated thrombocytopenia is a common finding in prenatal care.
  • Severe forms of thrombocytopenia are infrequent, necessitating careful monitoring and diagnosis.

Related Experiment Videos